Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy | NOVA. The University of Newcastle's Digital RepositoryTimothy P Hughes,Susan Branford,Julian Cooney, Michael F Leahy,Philip A Rowlings,John Catalano,Mark Hertzberg,Robin Filshie,A K Mills, K Fay, S Durrant,Henry Januszewicz,Deborah L White,David Joske,Craig Underhill, Scott Dunkley,Kevin Lynch,Andrew Grigg,John Reynolds,Rachel Koelmeyer,John F Seymour,Kerry Taylor,C Arthur,Anthony K Schwarer,James Mortonmag(2008)引用 23|浏览5暂无评分关键词novaAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要